Skip to content

Clinical trials

Completed Phase 2/3 Parkinson Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 2/3 Status: Completed Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20061
20073
20082
20093
20113
20123
20131
20153
20161
20182
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Co., Ltd.2
Adamas Pharmaceuticals, Inc.1
Alessandra Tanuri Magalhães1
Avid Radiopharmaceuticals1
Biotie Therapies Inc.1
Boehringer Ingelheim1
Britannia Pharmaceuticals Ltd.1
Federal University of Bahia1
Fudan University1
Hong Kong Baptist University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease29
Deglutition Disorders1
Disorders of Excessive Somnolence1
Dyskinesias1
Hypotension, Orthostatic1
Multiple Sclerosis1
Parkinsonian Disorders1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.